Malin Corporation | MLC - Assets

Stock Price
7.45
Daily Change
-0.15 -1.97%
Monthly
-6.88%
Yearly
-12.35%
Q2 Forecast
7.23

Malin Corporation reported EUR198.5M in Assets for its fiscal semester ending in December of 2024.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
ALKERMES USD 4.26B 1.77B Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Eurofins Scientific SE EUR 10.99B 399.1M Dec/2025
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Lonza CHF 18.97B 164M Dec/2025
Malin Corporation EUR 198.5M 70.1M Dec/2024
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Ovoca Bio EUR 1.66M 9.75M Jun/2025
Revvity USD 12B 171.82M Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026